Markus Aschwanden
Overview
Explore the profile of Markus Aschwanden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
903
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schremmer T, Dejaco C, Recker F, Aschwanden M, Boumans D, Bruyn G, et al.
RMD Open
. 2025 Feb;
11(1).
PMID: 39915246
Objective: Ultrasonography is crucial for diagnosing giant cell arteritis (GCA); however, training opportunities are rare. This study tested the reliability of ultrasonography findings and measurements of the intima-media thickness (IMT)...
2.
Reinert N, Wetzel K, Franzeck F, Morgenstern M, Aschwanden M, Wolff T, et al.
J Bone Jt Infect
. 2024 Jul;
9(3):183-190.
PMID: 39040989
: Standardization of diagnostic and treatment concepts in diabetes-related foot infection (DFI) is challenging. In 2019, specific recommendations regarding diagnostic principles and antibiotic therapy (ABT) for DFI, including the one...
3.
Kohn P, Pitasi C, Vilela V, Vargas-Santos A, Aschwanden M, Hemmig A, et al.
Clin Rheumatol
. 2024 Jun;
43(8):2647-2651.
PMID: 38907849
No abstract available.
4.
Hemmig A, Rottenburger C, Baruti L, Mensch N, Aschwanden M, Kyburz D, et al.
Semin Arthritis Rheum
. 2024 Mar;
66:152425.
PMID: 38442463
Objectives: To investigate the value of [F]fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and magnetic resonance imaging (MRI) in predicting relapse after treatment discontinuation in patients with large-vessel giant cell arteritis...
5.
Hemmig A, Rottenburger C, Aschwanden M, Berger C, Kyburz D, Pradella M, et al.
Diagnostics (Basel)
. 2023 Dec;
13(23).
PMID: 38066800
We sought to investigate magnetic resonance imaging (MRI) parameters that correspond to vasculitis observed via [F]FDG positron emission tomography/computed tomography (PET/CT) and ultrasound in patients with large-vessel giant cell arteritis...
6.
Vrotniakaite-Bajerciene K, Rutsche S, Calzavarini S, Quarroz C, Stalder O, Mean M, et al.
J Clin Med
. 2023 Sep;
12(18).
PMID: 37762997
It is currently unknown whether thrombin generation is associated with venous thromboembolism (VTE) recurrence, major bleeding, or mortality in the elderly. Therefore, our aim was to prospectively study the association...
7.
Hemmig A, Aschwanden M, Berger C, Kyburz D, Mensch N, Staub D, et al.
Rheumatology (Oxford)
. 2023 Aug;
63(6):1523-1527.
PMID: 37647653
Objectives: To investigate the hypothesis that a history of PMR is associated with a more severe and damaging disease course in newly diagnosed GCA patients. Methods: This was a retrospective...
8.
Meyer B, Kunz N, Seki S, Higgins R, Ghosh A, Hupfer R, et al.
J Clin Immunol
. 2023 Aug;
43(8):1857.
PMID: 37572200
No abstract available.
9.
Meyer B, Kunz N, Seki S, Higgins R, Ghosh A, Hupfer R, et al.
J Clin Immunol
. 2023 Jul;
43(8):1840-1856.
PMID: 37477760
Mutations in CD46 predispose to atypical hemolytic uremic syndrome (aHUS) with low penetrance. Factors driving immune-dysregulatory disease in individual mutation carriers have remained ill-understood. In addition to its role as...
10.
Mensch N, Hemmig A, Aschwanden M, Imfeld S, Stegert M, Recher M, et al.
RMD Open
. 2023 Jul;
9(3).
PMID: 37460275
Objectives: We evaluated the feasibility of a rapid glucocorticoid tapering regimen to reduce glucocorticoid exposure in patients with giant cell arteritis (GCA) treated with glucocorticoids only. Methods: Newly diagnosed patients...